Biotechnology Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity? 5 years ago The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for… IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know 5 years ago Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding… IPO News: What to look for when Elevation Oncology makes its Wall Street debut 5 years ago The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that… BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript 5 years ago BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations… Is Merck (MRK) stock still a buy after losing the vaccine race? 5 years ago After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the… LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market? 5 years ago For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges… Bio-Path Holdings, Inc. (BPTH) Q1 2021 Earnings Call Transcript 5 years ago Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O'Connor -- Investor Relations, Stern Investor… ImmunoGen’s post-earnings dip could be a good buying opportunity 5 years ago Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the… Veru Inc. (VERU) Q2 2021 Earnings Call Transcript 5 years ago Veru Inc. (NASDAQ: VERU) Q2 2021 earnings call dated May. 12, 2021 Corporate Participants: Sam Fisch -- Director of Investor Relations Mitchell… FibroGen Inc. (FGEN) Q1 2021 Earnings Call Transcript 5 years ago FibroGen Inc. (NASDAQ: FGEN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy… Immunogen, Inc. (IMGN) Q1 2021 Earnings Call Transcript 5 years ago Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O'Konek -- Senior Director of Corporate Communications… Regeneron Pharmaceuticals Inc. (REGN) Q1 2021 Earnings Call Transcript 5 years ago Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Justin Holko -- Vice President, Investor Relations… Moderna (MRNA): COVID-19 vaccine helps company deliver first ever profitable quarter 5 years ago Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first… CVS Health gets a shot in the arm from COVID care: Is the stock a buy? 5 years ago After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost… AbbVie (ABBV) Stock: Here’s what you need to know before investing 5 years ago AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant's… Biomarin Pharmaceutical Inc. (BMRN) Q1 2021 Earnings Call Transcript 5 years ago Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Traci McCarty -- Vice President of Investor… BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q1 financial results 5 years ago Bristol-Myers Squibb Company (NYSE: BMY) reported first quarter 2021 earnings results today. Revenues increased 3% year-over-year to $11.1 billion. Net… Infographic: How Biogen (BIIB) performed in Q1 2021 5 years ago Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On… It’s worth keeping an eye on Vertex Pharma (VRTX) stock. Here’s why 5 years ago After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical… Will restructuring, cost-cutting help Walgreens (WBA) beat COVID blues? 5 years ago The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy… Here’s what you need to know before investing in Amgen (AMGN) 5 years ago The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely… Next» « Previous